Abstract
Abstract:
The present invention relates to crystalline forms of (4S)4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide represented by the following structural formula-1, which is referred to as Finerenone.
Formula-1
The present invention also relates to a process for the preparation of crystalline forms of Finerenone.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan, Sajja Eswaraiah, Sagyam Rajeshwar Reddy, Kammari Bal Raju, Edulakanti Jhansi, "Crystalline forms of (4S)4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and process for its preparation thereof", Technical Disclosure Commons, (May 13, 2024)
https://www.tdcommons.org/dpubs_series/6995